Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?

Files in this item

This item appears in the following Collection(s)

Search DSpace



Browse

My Account

Statistics